These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 366493)

  • 1. [Prevention of recurrence of bronchial carcinomas after surgery by means of the mistletoe extract Iscador. Results of a clinical study from 1969-1971].
    Salzer G; Havelec L
    Onkologie; 1978 Dec; 1(6):264-7. PubMed ID: 366493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Investigation to improve the survival of patients with bronchial carcinomas "radically operated" (author's transl)].
    Salzer G
    Z Erkr Atmungsorgane; 1975 Feb; 142(2):127-31. PubMed ID: 1226878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [After care of irradiated genital carcinoma using the Viscum album preparation Iscador for the prevention of recurrences].
    Fellmer KE
    Med Klin; 1967 Feb; 62(8):305-7. PubMed ID: 4297248
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomised and non-randomised prospective controlled cohort studies in matched-pair design for the long-term therapy of breast cancer patients with a mistletoe preparation (Iscador): a re-analysis.
    Grossarth-Maticek R; Ziegler R
    Eur J Med Res; 2006 Nov; 11(11):485-95. PubMed ID: 17182361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Postoperative Viscum album therapy after surgery of breast neoplasms].
    Leroi R
    Helv Chir Acta; 1977 Jun; 44(3):403-14. PubMed ID: 617173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study.
    Grossarth-Maticek R; Kiene H; Baumgartner SM; Ziegler R
    Altern Ther Health Med; 2001; 7(3):57-66, 68-72, 74-6 passim. PubMed ID: 11347286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador).
    Grossarth-Maticek R; Ziegler R
    Forsch Komplementmed; 2006 Oct; 13(5):285-92. PubMed ID: 17057389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Iscador--mistletoe extract for cancer treatment. Documentation No. 10].
    Schweiz Rundsch Med Prax; 1988 Jan; 77(4):69-74. PubMed ID: 3279479
    [No Abstract]   [Full Text] [Related]  

  • 9. [The local treatment of malignant pleural exudations with Iscador (a drug obtained from Misteltoe). Preliminary report (author's transl)].
    Salzer G
    Osterr Z Onkol; 1977; 4(1):13-4. PubMed ID: 333344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective controlled cohort studies on long-term therapy of ovairian cancer patients with mistletoe (Viscum album L.) extracts iscador.
    Grossarth-Maticek R; Ziegler R
    Arzneimittelforschung; 2007; 57(10):665-78. PubMed ID: 18074761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized and non-randomized prospective controlled cohort studies in matched pair design for the long-term therapy of corpus uteri cancer patients with a mistletoe preparation (Iscador).
    Grossarth-Maticek R; Ziegler R
    Eur J Med Res; 2008 Mar; 13(3):107-20. PubMed ID: 18499556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticarcinogenic and antimetastatic activity of Iscador.
    Kuttan G; Menon LG; Antony S; Kuttan R
    Anticancer Drugs; 1997 Apr; 8 Suppl 1():S15-6. PubMed ID: 9179361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of Iscador (Viscum praeparatum M.) on the Walker carcinosarcoma of the rat (author's transl)].
    Seitz W
    Wien Klin Wochenschr; 1975 Feb; 87(4):131-2. PubMed ID: 1130081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on additional Iscador therapy in the management of women with surgically and radiotherapeutically treated genital carcinoma].
    Leroi R
    Gynaecologia; 1969; 167(3):158-70. PubMed ID: 4305038
    [No Abstract]   [Full Text] [Related]  

  • 15. Pleura carcinosis. Cytomorphological findings with the mistletoe preparation iscador and other pharmaceuticals.
    Salzer G
    Oncology; 1986; 43 Suppl 1():66-70. PubMed ID: 3808576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival of cancer patients treated with mistletoe extract (Iscador): a systematic literature review.
    Ostermann T; Raak C; Büssing A
    BMC Cancer; 2009 Dec; 9():451. PubMed ID: 20021637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [What prospects of success does Iscador therapy offer in advanced ovarian cancer?].
    Hassauer W; Gutsch J; Burkhardt R
    Onkologie; 1979 Feb; 2(1):28-36. PubMed ID: 392367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective controlled cohort studies on long-term therapy of cervical cancer patients with a mistletoe preparation (Iscador).
    Grossarth-Maticek R; Ziegler R
    Forsch Komplementmed; 2007 Jun; 14(3):140-7. PubMed ID: 17596694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of fermented and unfermented mistletoe preparations on cultured tumor cells.
    Ribéreau-Gayon G; Jung ML; Di Scala D; Beck JP
    Oncology; 1986; 43 Suppl 1():35-41. PubMed ID: 3808575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Topical treatment of malignant pleural effusions with iscador, a mistletoe preparation (author's transl)].
    Salzer G; Müller H
    Prax Klin Pneumol; 1978 Nov; 32(11):721-9. PubMed ID: 724639
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.